Drug Trial Radar · NCT06688292
The Safety and Effectiveness of Taneasy and Actein in COPD Patients
Last checked: Nov 20, 2026Latest source record: Feb 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
42
Actual
Start
Sep 20, 2024
Primary completion
Dec 31, 2024
Study completion Dec 31, 2024
Sponsor
- Lead sponsor
- Bun Yao Biotechnology Co., LtdIndustry
- Sponsor type
- Industry
- Collaborators
- KGS Pharmamate Co., Ltd; Taichung Veterans General Hospital
- First posted
- Nov 14, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of Taneasy 600mg granules and Actein effervescent tablets 600MG administered twice daily for 14 days in treatment of COPD Disease.
Conditions
- COPD (Chronic Obstructive Pulmonary Disease)
Interventions
Taneasy 600mg granulesDrug
Treatment of respiratory affections characterized by thick and viscous hypersecretion due to acute bronchitis,chronic bronchitis and its exacerbation, plumonary emphysema,mucoviscidosis and bronchiectasis.
Actein effervescent 600mgDrug
Treatment of respiratory affections characterized by thick and viscous hypersecretion due to acute bronchitis,chronic bronchitis and its exacerbation, pulmonary emphysema, mucoviscidosis and bronchiectasis.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the safety and efficacy of Taneasy 600mg granules and Actein effervescent tablets 600MG administered twice daily for 14 days in treatment of COPD Disease.Time frame: one month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Taichung Veterans General Hospital
Taichung, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.